2008
DOI: 10.1159/000146077
|View full text |Cite
|
Sign up to set email alerts
|

Fourth International Stroke Summit. Nanjing, China, July 25–27, 2008

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In our previous study, we also showed that intravenous administration of anti-TLR4 antibody 30 min prior to occlusion of the middle cerebral artery attenuated ischemia-reperfusion damage and improved mice behavioral performance [34]. In this study, we were interested in assessing the effect of neutralizing TLR4 using Mts510 in mice with ICH.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In our previous study, we also showed that intravenous administration of anti-TLR4 antibody 30 min prior to occlusion of the middle cerebral artery attenuated ischemia-reperfusion damage and improved mice behavioral performance [34]. In this study, we were interested in assessing the effect of neutralizing TLR4 using Mts510 in mice with ICH.…”
Section: Resultsmentioning
confidence: 99%
“…Mice in group 4) received class-match control rat anti-mouse mAb (IgG2α, 200 μg/mL, LifeSpan Biosciences, Seattle, WA, USA). The dose of antibodies used was based on our previous findings [34]. Cerebral water content and extent of neurological impairment were measured 3 days after ICH.…”
Section: Methodsmentioning
confidence: 99%